About Regulus Therapeutics
Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual property estate to retain its leadership in the microRNA field.
Regulus is located in San Diego, California and is led by a seasoned executive team experienced in corporate management, business, science, drug discovery and development. Regulus' scientific advisory board consists of world-class scientists and some of the foremost authorities in the field of microRNA research.
|
|
|
11-50 employees
View all Regulus Therapeutics employees
|
|
Biotechnology
|
|
San Diego, CA 92121, US
|
|
2007
|
|
Microrna And Great Company Culture
|
Regulus Therapeutics Alternatives
Frequently Asked Questions about Regulus Therapeutics
Jay Hagan is the CEO of Regulus Therapeutics. To contact Jay Hagan email at [email protected] or [email protected].
The decision makers in Regulus Therapeutics are Brian Campion, Christopher Aker, Curtis Monnig, etc. Click to Find Regulus Therapeutics decision makers emails.
Regulus Therapeutics Staff Directory
Search Regulus Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
